Core 2 GlcNAc-T inhibitors

Details for Australian Patent Application No. 2006264635 (hide)

Owner BTG International Limited

Inventors Chibber, Rakesh

Agent Watermark

Pub. Number AU-A-2006264635

PCT Pub. Number WO2007/003948

Priority 0513888.8 06.07.05 GB

Filing date 6 July 2006

Wipo publication date 11 January 2007

International Classifications

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/003948 Priority application(s): WO2007/003948

29 May 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Chibber, Rakesh and Hagan, Russell

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006264637-Core 2 beta(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis

2006264633-Security device